Document is current
Any future updates will be listed below
-
Authors
Quandt, Fanny
Flottmann, Fabian
Madai, Vince I.
Alegiani, Anna
Küpper, Clemens
Kellert, Lars
Hilbert, Adam
Frey, Dietmar
Liebig, Thomas
Fiehler, Jens
Goyal, Mayank
Saver, Jeffrey L.
Gerloff, Christian
Thomalla, Götz
Tiedt, Steffen https://orcid.org/0000-0002-8817-8457
,
Berrouschot, J.
Bormann, A.
Bohner, G.
Nolte, C. H.
Siebert, E.
Zweynert, S.
Dorn, F.
Petzold, G. C.
Keil, F.
Pfeilschifter, W.
Hamann, G. F.
Braun, M.
Eckert, B.
Röther, J.
Alegiani, A.
Fiehler, J.
Gerloff, C.
Thomalla, G.
Kraemer, C.
Gröschel, K.
Uphaus, T.
Kellert, L.
Tiedt, S.
Trumm, C.
Boeckh-Behrens, T.
Wunderlich, S.
Ludolph, A.
Petersen, M.
Stögbauer, F.
Ernemann, U.
Poli, S.
Khatri, P.
Bendszuz, M.
Bracard, S.
Broderick, J.
Campbell, B.
Ciccone, A.
Davalos, A.
Davis, S.
Demchuk, A.
Diener, H. C.
Dippel, D.
Donnan, G. A.
Ducrocq, X.
Fiehler, J.
Fiorella, D.
Ford, G.
Goyal, M.
Hacke, W.
Hill, M.
Jahan, R.
Jauch, E.
Jovin, T.
Kidwell, C.
Lees, K. R.
Liebeskind, D. S.
Majoie, C. B.
Martins, S.
Mitchell, P.
Mocco, J.
Muir, K.
Nogueira, R. G.
Saver, J. L.
Schonewille, W. J.
Siddiqui, A. H.
Thomalla, G.
Tomsick, T. A.
Turk, A. S.
van Zwam, W. H.
White, P.
Yoshimura, S.
Zaidat, O. O.
-
Funding
Funding for this research was provided by:
Corona Foundation
Universitätsklinik München
- License Information
-
More Information
Article History
Received: 7 January 2022
Revised: 19 April 2022
Accepted: 22 May 2022
First Online: 7 June 2022
Declarations
:
: FF reports personal fees from Eppdata. LK has received funding for travel or speaker honoraria from Bayer Vital, Boehringer Ingelheim, Bristol-Meyer-Squibb, Daiichi Sankyo, and Pfizer outside of this study. AH reports a grant from the European Commission Horizon2020 program (PRECISE4Q Grant No. 777 107, coordinator: Dietmar Frey) during the conduct of the study. DF reports grants from the European Commission: Horizon2020 program (PRECISE4Q Grant No. 777 107, coordinator: DF) and grants from the Federal Ministry of Research and Education (GO-Bio Grant No. 031B0154, lead: DF) during the conduct of the study. JF reports grants and personal fees from Anandis, Cerenovus, Microvention, Medtronic, Stryker, and personal fees from Phenox and Penumbra, all outside the submitted work. JF also serves as the CEO of Eppdata. MG reports personal fees from Medtronic, Stryker, Microvention, and Mentice, all outside the submitted work. In addition, MG has a patent on “Systems of acute stroke diagnosis” licensed to GE Healthcare, and a patent on “Systems of intracranial access” licensed to Microvention. CG reports personal fees from Amgen, Boehringer Ingelheim, Daiichi Sankyo, Abbott, Prediction Biosciences, Novartis, and Bayer, all outside the submitted work. GT reports grants and personal fees from Bayer, and personal fees from Acandis, BristolMyersSquibb/Pfizer, Boehringer Ingelheim, Daiichi Sankyo, Portola, and Stryker, all outside the submitted work. ST received funding from the Corona foundation outside of the submitted work. All the other authors declare no competing interests.
